- Home
- SNY vs HCA Comparison
SNY vs HCA Comparison
Compare SNY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNY | HCA |
|---|---|---|
| Founded | 1994 | 1968 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8B | 119.9B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | SNY | HCA |
|---|---|---|
| Price | $44.49 | $532.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 21 |
| Target Price | $61.50 | ★ $524.26 |
| AVG Volume (30 Days) | ★ 4.2M | 984.9K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | ★ 3.55% | 0.58% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | N/A | ★ 28.33 |
| Revenue | N/A | ★ $75,600,000,000.00 |
| Revenue This Year | $2.62 | $5.10 |
| Revenue Next Year | $6.38 | $4.94 |
| P/E Ratio | ★ $6.14 | $18.87 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $44.62 | $310.18 |
| 52 Week High | $60.12 | $552.90 |
Technical Indicators
Market Signals| Indicator | SNY | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 55.96 |
| Support Level | N/A | $522.05 |
| Resistance Level | $48.97 | $552.90 |
| Average True Range (ATR) | 0.70 | 12.15 |
| MACD | -0.29 | -1.34 |
| Stochastic Oscillator | 8.84 | 37.37 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.